BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//81qd - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:81qd
X-ORIGINAL-URL:https://www.81qd.com
X-WR-CALDESC:Events for 81qd
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20270314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20271107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260322
DTEND;VALUE=DATE:20260326
DTSTAMP:20260218T202854Z
CREATED:20260213T150006Z
LAST-MODIFIED:20260218T202854Z
UID:1463-1774137600-1774483199@www.81qd.com
SUMMARY:MAPS 2026
DESCRIPTION:81qd at MAPS Americas 2026: For Medical Affairs Leaders Shaping Evidence\, Engagement\, and Impact in 2026\n\n  \n81qd is heading to MAPS Americas 2026 to connect with Medical Affairs leaders shaping the future of evidence and engagement. This year in Denver\, we’re highlighting how Medical Affairs teams can apply real‑world data\, evidence analytics\, and precision expert identification to elevate their strategic impact across the product lifecycle. \nOur team will be on site\, attending to discuss the evolving role of Medical Affairs—particularly how field medical teams\, evidence strategists\, and medical leadership can use data to drive more credible\, informed\, and actionable decision-making. \nSubmit a meeting request\, and a member of our team will follow up to coordinate timing during the conference. \n\n\nWhy Connect with 81qd at MAPS 2026\nMedical Affairs teams are navigating increasing complexity across evidence expectations\, stakeholder engagement\, and the use of real-world data to inform strategy and execution. \nAt MAPS\, many teams are asking similar questions: \n\nHow do we identify true clinical influence beyond traditional KOL lists?\nHow can real-world data better inform Medical Affairs strategy and planning?\nHow do we support field medical teams with insight that is credible\, usable\, and relevant?\n\nMAPS provides a timely opportunity to discuss how these challenges are being addressed across Medical Affairs organizations today. \n\n  \n\n\nHow 81qd Supports Medical Affairs\nIdentifying the Right KOLs\nPinpointing the experts who truly influence clinical practice requires more than traditional KOL lists.\n81qd helps Medical Affairs teams: \n\nApply proprietary methodologies for KOL identification\, ranking\, and network mapping\nUse real‑world treatment behavior to uncover clinical influence\nUnderstand referral patterns and institutional dynamics that shape decision-making\nIdentify patient segments and stakeholder roles that matter most for evidence and engagement strategy\n\nExplore how our methodology drives higher-impact engagement:\n→ Identifying Key Payer & KOL Advisors for Market Access Success \n  \n\nEngaging KOLs Effectively\nData-informed strategic engagement helps Medical Affairs teams build stronger\, more credible relationships.\nWe support teams through: \n\nOmnichannel medical engagement—including digital scientific content\, congress strategy\, and insight‑powered interactions\nAdvisory board optimization and targeted scientific exchange\nEngagement plans informed by behavioral science and real-world evidence\n\nSee how data-supported planning strengthens Medical Affairs execution:\n→ Optimizing Pre‑Launch Medical Affairs Engagement \n\n\n  \n\nMeasuring Medical Affairs Success\nMedical Affairs leaders are under increased pressure to demonstrate impact.\n81qd provides analytics to help teams: \n\nTrack behavioral shifts\, scientific engagement\, and market impact\nUse real-world data applications to improve trial feasibility\, referral pathways\, and site engagement\nApply advanced analytics for evidence-based decision-making and strategic refinement\n\nLearn how clinical behavior insights accelerate improved outcomes:\n→ Enhancing Clinical Practice Through Behavior Change Frameworks \n\n\n\nConnect With Us at MAPS Americas 2026\nIf you’re attending MAPS\, we welcome the opportunity to meet and discuss your Medical Affairs priorities for 2026 and beyond. \nSubmit a meeting request\, and a member of our team will follow up to coordinate timing during the conference.
URL:https://www.81qd.com/event/maps-2026/
LOCATION:Hyatt Regency Denver at Colorado Convention Center\, 650 15th St.\, Denver\, CO\, 80202\, United States
ATTACH;FMTTYPE=image/png:https://www.81qd.com/wp-content/uploads/maps_americas2026_Denver_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260415
DTEND;VALUE=DATE:20260417
DTSTAMP:20260410T192816Z
CREATED:20260410T141533Z
LAST-MODIFIED:20260410T192816Z
UID:1474-1776211200-1776383999@www.81qd.com
SUMMARY:TLL Summit Houston
DESCRIPTION:81qd at the TLL Summit Houston 2026: Turning KOL Engagement into Insight That Drives Strategy\n\n  \n81qd is at the TLL Summit Houston 2026\, connecting with Thought Leader Liaisons focused on turning KOL insight into action across the organization. \nAs expectations evolve\, TLLs are being asked to deliver insight that is consistent\, credible\, and actionable. 81qd brings structure to KOL engagement and translates insight into decisions that shape strategy. \nOur team will be on site to connect with TLLs focused on strengthening how insight informs engagement. \nSubmit a meeting request\, and a member of our team will follow up to coordinate timing during the conference. \n\n\nFeatured Panel: Two Truths and a Lie About KOL Sentiment\nAssessing KOL sentiment is central to the TLL role\, shaping how insights are interpreted and used to guide engagement planning. This panel challenges common assumptions and explores how sentiment is defined\, measured\, and applied in practice. \nDiscussion topics include: \n\nHow KOL sentiment is gathered and interpreted across organizations\nWhere perception can be misleading and how to identify meaningful signals\nThe distinction between sentiment and true advocacy\nHow sentiment informs engagement strategy and internal decision-making\n\n\n  \n\n\nWhy This Matters Now\nThe TLL role is expanding\, with greater expectations to influence strategy across the organization. \nAt the same time\, many teams are still relying on fragmented inputs\, inconsistent definitions of sentiment\, and limited visibility into real influence. \nThe challenge isn’t collecting more feedback. It’s identifying meaningful signals and turning them into insight that drives decisions. \n  \n\nHow 81qd Translates TLL Insight into Action\nWe help TLL teams move from fragmented feedback to insight that drives decisions: \n\nStructure KOL sentiment so it is consistent and measurable across teams\nIdentify true influence using real-world behavior\, not just perception\nInform engagement strategy with data-driven insight on advocates\, detractors\, and shifts\nScale impact across the organization by translating field insights into decision-ready outputs\n\n  \n\n\n\nConnect With Us at the TLL Summit\nIf you’re attending\, we’d welcome the opportunity to connect. \nSubmit a meeting request\, and a member of our team will follow up to coordinate timing during the conference.
URL:https://www.81qd.com/event/tll-summit-houston/
LOCATION:The Westin Houston Medical Center\, 1709 Dryden Rd\, Houston\, TX\, 77030\, United States
ATTACH;FMTTYPE=image/png:https://www.81qd.com/wp-content/uploads/TLL_2026_Houston.png
ORGANIZER;CN="Momentum Events":MAILTO:info@momentumevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260918
DTSTAMP:20260828T185526Z
CREATED:20260806T172538Z
LAST-MODIFIED:20260828T185526Z
UID:1498-1789344000-1789689599@www.81qd.com
SUMMARY:81qd at Fierce Pharma Week 2026
DESCRIPTION:How Pharma Teams Turn Clinical Network Data Into Commercial Intelligence\n  \n81qd is sponsoring a Data\, Analytics & Commercial Intelligence Track discussion at Fierce Pharma Week 2026 featuring panelists from Merck. \nThe moderated session will explore how clinical and relationship data can help pharma teams build a more connected view of the stakeholder landscape\, inform commercial planning\, and support more data-driven marketing and engagement decisions. \n\nFeatured Session\nTurning Clinical Network Data Into Commercial Intelligence\nDate: Wednesday\, September 16\nTime: 11:45 AM–12:10 PM ET \nIn this 25-minute discussion\, Susan Abedi of 81qd will moderate a conversation with Merck panelists Shelia Carter\, Associate Director\, HIV Franchise Marketing & Business Operations\, and Kristen Greco\, MBA\, Associate Director\, Cardiovascular Marketing\, on how network analytics can turn clinical and relationship data into commercial intelligence. \nThe discussion will focus on how data can reveal patterns across HCP and stakeholder relationships\, support audience prioritization and footprint expansion\, and inform more data-driven marketing and engagement decisions. \n\nWhat Attendees Will Learn\n\nUnderstand how clinical and relationship data can help teams build a more connected view of the HCP and stakeholder landscape\nLearn how network analytics can reveal patterns that inform customer planning\, audience prioritization\, and footprint expansion\nExplore how commercial teams can translate network insights into more data-driven marketing and HCP engagement decisions\nDiscuss how network analysis helped identify a new engagement KPI tied to marketing and commercial objectives\n\nPanelists\n\nSusan Abedi\, Chief Strategy Officer\, 81qd\nShelia Carter\, Associate Director\, HIV Franchise Marketing & Business Operations\, Merck\nKristen Greco\, MBA\, Associate Director\, Cardiovascular Marketing\, Merck\n\n\nMeet 81qd at Fierce Pharma Week\nInterested in learning how clinical network data and network analytics can support more informed commercial planning and HCP engagement strategy? \nConnect with 81qd at Fierce Pharma Week 2026 to discuss how data-driven insights can help your team identify stakeholder relationships\, engagement opportunities\, and new ways to measure impact. \nRequest a meeting
URL:https://www.81qd.com/event/81qd-at-fierce-pharma-week-2026/
LOCATION:Pennsylvania Convention Center\, Philadelphia\, PA
ATTACH;FMTTYPE=image/png:https://www.81qd.com/wp-content/uploads/fpw2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261015
DTSTAMP:20260921T162654Z
CREATED:20260806T183914Z
LAST-MODIFIED:20260921T162654Z
UID:1510-1791849600-1792022399@www.81qd.com
SUMMARY:81qd at the TLL Engagement Summit Philadelphia 2026
DESCRIPTION:Elevating the TLL Toolkit: Content That Enables More Meaningful KOL Engagement\n81qd is proud to sponsor the 7th TLL Engagement Summit in Philadelphia\, taking place October 13–14\, 2026. Join us for a featured panel exploring how the right content can equip TLLs for more relevant\, valuable\, and engaging interactions with KOLs. \nAbout the Session\nContent is a critical enabler of meaningful TLL interactions with KOLs\, but what does effective TLL content actually look like? \nThis panel will explore the role content plays in supporting KOL engagement\, from defining the right content categories and development considerations to navigating review\, common pitfalls\, and practical watchouts. Panelists will share perspectives and best practices for developing resources that help TLLs deliver greater value in their KOL interactions. \nWhat Attendees Will Learn\n\nWhich types of content best support meaningful TLL and KOL interactions\nHow to develop resources that reflect the needs of both TLLs and KOLs\nKey considerations for content development and review\nCommon pitfalls that can limit the usefulness of TLL materials\n\nModerator\nSusan Abedi\, Chief Strategy Officer\, 81qd \nPanelists\nJennifer Zumoff\, National Director\, Thought Leader Liaisons\, Neuroscience\, Johnson & Johnson \nClaire Finn\, PhD\, Sr. Vice President\, Medical\, Synapse Medical Communications \n\nTLL Engagement Summit Philadelphia\nDate: October 13–14\, 2026Location: Philadelphia\, PA \n\nMeet 81qd in Philadelphia\nConnect with 81qd at the TLL Engagement Summit to explore how data\, analytics\, and network intelligence can support thought leader identification\, stakeholder planning\, and more informed engagement strategies. \n\nRequest a Meeting
URL:https://www.81qd.com/event/81qd-at-the-tll-engagement-summit-philadelphia-2026/
LOCATION:Convene\, 2001 Market Street\, Philadelphia\, PA\, 19103\, United States
ORGANIZER;CN="Momentum Events":MAILTO:info@momentumevents.com
END:VEVENT
END:VCALENDAR